Endothelin: a review of its effects and possible mechanisms of action.

The recently identified endothelium-derived peptide, endothelin, is a potent vasoconstrictor, but also binds specifically to many types of smooth muscle and to nerve tissue. Endothelin has been detected in plasma and may have physiological or pathological functions. Like other agonists, endothelin increases the turnover of phosphatidyl inositol and liberates intracellular stocks of Ca2+. It also increases plasmalemmal Ca2+ permeability, an effect that is antagonized by calcium entry blockers in some tissues. However, the characteristics of this antagonism are not always typical of that seen when other types of agonists are employed. It seems that in at least some cell types endothelin might activate specific L-type Ca2+ channels indirectly, perhaps secondarily to the activation of another type of cation channel. The endothelin originally described is one of a family of peptides that are closely related to the sarafotoxins. The comparative pharmacology of these peptides and of some analogues of the originally described endothelin have revealed some surprising differences and may indicate the existence of different endothelin receptors.